Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

CYP1B1 prevents proteasome-mediated XIAP degradation by inducing PKCε activation and phosphorylation of XIAP.

Baek HS, Kwon YJ, Ye DJ, Cho E, Kwon TU, Chun YJ.

Biochim Biophys Acta Mol Cell Res. 2019 Sep 4;1866(12):118553. doi: 10.1016/j.bbamcr.2019.118553. [Epub ahead of print]

PMID:
31493422
2.

Cytochrome P450 1B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation.

Belous AR, Hachey DL, Dawling S, Roodi N, Parl FF.

Cancer Res. 2007 Jan 15;67(2):812-7.

3.

Induction of cytochrome P450 1B1 and catechol estrogen metabolism in ACHN human renal adenocarcinoma cells.

Spink DC, Spink BC, Cao JQ, Gierthy JF, Hayes CL, Li Y, Sutter TR.

J Steroid Biochem Mol Biol. 1997 Jun;62(2-3):223-32.

PMID:
9393958
4.

Oroxylin A, a methylated metabolite of baicalein, exhibits a stronger inhibitory effect than baicalein on the CYP1B1-mediated carcinogenic estradiol metabolite formation.

An D, Song Z, Yi Y, Zhang Q, Liu J, Zhang Y, Zhou J, Zhao G, Cong D, Li N, Lu Y, Chen X, Zhao D.

Phytother Res. 2019 Apr;33(4):1033-1043. doi: 10.1002/ptr.6297. Epub 2019 Jan 24.

PMID:
30680817
5.

The catecholestrogen, 2-hydroxyestradiol-17beta, acts as a G protein-coupled estrogen receptor 1 (GPER/GPR30) antagonist to promote the resumption of meiosis in zebrafish oocytes.

Chourasia TK, Pang Y, Thomas P.

Biol Reprod. 2015 Mar;92(3):69. doi: 10.1095/biolreprod.114.125674. Epub 2015 Jan 21.

PMID:
25609836
6.

Long-term exposure of 4-hydroxyestradiol induces the cancer cell characteristics via upregulating CYP1B1 in MCF-10A cells.

Lanxiang W, Bin W, Ge X, Yutang H, Chunjie W, Honghao Z.

Toxicol Mech Methods. 2019 Nov;29(9):686-692. doi: 10.1080/15376516.2019.1650146. Epub 2019 Aug 30.

PMID:
31364906
7.

Nitidine Chloride-Induced CYP1 Enzyme Inhibition and Alteration of Estradiol Metabolism.

Mao X, Wang J, Wang Q, Yang L, Li Y, Lin H, Peng Y, Zheng J.

Drug Metab Dispos. 2019 Aug;47(8):919-927. doi: 10.1124/dmd.119.086892. Epub 2019 May 30.

PMID:
31147316
8.

Regioselective 2-hydroxylation of 17beta-estradiol by rat cytochrome P4501B1.

Rahman M, Hayes Sutter C, Emmert GL, Sutter TR.

Toxicol Appl Pharmacol. 2006 Nov 1;216(3):469-78. Epub 2006 Jun 15.

PMID:
16893557
9.
10.

Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1.

Dawling S, Roodi N, Parl FF.

Cancer Res. 2003 Jun 15;63(12):3127-32.

11.

CYP1B1 Enhances Cell Proliferation and Metastasis through Induction of EMT and Activation of Wnt/β-Catenin Signaling via Sp1 Upregulation.

Kwon YJ, Baek HS, Ye DJ, Shin S, Kim D, Chun YJ.

PLoS One. 2016 Mar 16;11(3):e0151598. doi: 10.1371/journal.pone.0151598. eCollection 2016.

12.

Differences in 4-hydroxyestradiol levels in leukocytes are related to CYP1A1(∗)2C, CYP1B1(∗)3 and COMT Val158Met allelic variants.

Martínez-Ramírez OC, Pérez-Morales R, Petrosyan P, Castro-Hernández C, Gonsebatt ME, Rubio J.

Steroids. 2015 Oct;102:1-6. doi: 10.1016/j.steroids.2015.06.014. Epub 2015 Jun 27.

PMID:
26123186
14.
15.

Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells.

Seeger H, Wallwiener D, Kraemer E, Mueck AO.

Maturitas. 2006 Apr 20;54(1):72-7. Epub 2005 Oct 4.

PMID:
16213115
17.
18.
19.

Prostaglandin E2 induces CYP1B1 expression via ligand-independent activation of the ERalpha pathway in human breast cancer cells.

Han EH, Kim HG, Hwang YP, Song GY, Jeong HG.

Toxicol Sci. 2010 Apr;114(2):204-16. doi: 10.1093/toxsci/kfq013. Epub 2010 Jan 21.

PMID:
20093341
20.

Tetra-methoxystilbene modulates ductal growth of the developing murine mammary gland.

Kim T, Park H, Yue W, Wang JP, Atkins KA, Zhang Z, Rogan EG, Cavalieri EL, Mohammad KS, Kim S, Santen RJ, Aiyar SE.

Breast Cancer Res Treat. 2011 Apr;126(3):779-89. doi: 10.1007/s10549-010-1301-5. Epub 2010 Dec 18.

Supplemental Content

Support Center